ABTL0812
ABTL0812 is an investigational drug that is being studied for its potential use in the treatment of various types of cancer. It is a small molecule that targets the PI3K/AKT/mTOR pathway, which is often dysregulated in cancer cells, leading to uncontrolled cell growth and survival.
Mechanism of Action
ABTL0812 works by inhibiting the PI3K/AKT/mTOR pathway, a critical signaling pathway that regulates cell growth, proliferation, and survival. By targeting this pathway, ABTL0812 aims to reduce the growth and survival of cancer cells. The inhibition of this pathway can lead to apoptosis (programmed cell death) and reduced tumor growth.
Clinical Development
ABTL0812 is currently undergoing clinical trials to evaluate its safety and efficacy in patients with various types of cancer, including lung cancer, endometrial cancer, and pancreatic cancer. Early-phase clinical trials have shown promising results, with some patients experiencing tumor shrinkage and disease stabilization.
Potential Benefits
The potential benefits of ABTL0812 include its ability to target a key pathway involved in cancer cell survival and proliferation. This makes it a promising candidate for combination therapy with other anticancer agents. Additionally, its oral administration route offers convenience for patients compared to intravenous therapies.
Side Effects
As with any investigational drug, ABTL0812 may have side effects. Common side effects observed in clinical trials include nausea, fatigue, and diarrhea. More serious side effects are being closely monitored in ongoing studies.
Future Directions
Further research is needed to fully understand the potential of ABTL0812 in cancer treatment. Ongoing and future clinical trials will provide more information on its efficacy, optimal dosing, and potential combination strategies with other therapies.
See Also
References
External Links
-
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
